OrthoSensor has announced it has raised $19 million in a private placement of series C preferred stock.

OrthoSensor, based in Dania Beach, FL, is a developer of intelligent orthopedic devices and data services.

Participating in the financing round were Bridger Healthcare and The Tullis Growth Fund.

OrthoSensor indicated the funding would be used to support the commercialization of VERASENSE, the company’s disposable, sensor-assisted, total knee replacement device, as well as to expand product development.